Program areas at IDSA
Idweek annual conference - in 2022, over 10,000 participants and exhibitors attended either in person or virtually. Idweek is the world's premier Infectious Diseases event. Idweek provides an opportunity for health professionals of varied backgrounds to learn from each other's knowledge, experience and expertise, for the improvement of patient care and public health. This is an inclusive meeting that offers access to internationally recognized leaders in the field and the opportunity to network with the most highly respected health professionals in Infectious Diseases, including hiv.
Idsa was awarded a cooperative agreement to support the cdc by providing resources to frontline health care professionals caring for patients with covid-19. The partnership brings numerous medical specialties together to share resources and to provide the latest information and guidance on treating those infected with covid-19 and preventing its spread. Through funding from cdc, Idsa experts support cdc's clinical call lines, providing guidance to health care providers treating covid-19 patients. The collaboration has also funded the flourishing covid-19 real-time learning network, an online center for frontline clinicians to learn, collaborate and share treatment best practices. Idsa's covid-19 practice guidelines on diagnostics, treatment and management also receive funding through the grant. Additionally, under the partnership, twice-monthly clinician teleconferences provide health care professionals access to experts with the latest information on this evolving virus as well as an opportunity to ask questions. The calls frequently draw more than 800 attendees.
Clinical Infectious Diseases (cid), the journal of Infectious Diseases (jid) and open forum Infectious Diseases (ofid) are scholarly journals published by Idsa in partnership with an outside publisher to disseminate the latest research on a variety of topics in the field to members and subscribers. Cid publishes original research, reviews and perspectives that all clinicians can use when caring for patients. Cid covers the clinical presentation, diagnosis, treatment and prevention of the full range of Infectious Diseases. The evaluation of current and novel treatments, microbiology, immunology and policies as they relate to patient care are highly prioritized. Published continuously since 1904, jid is the premier global journal for translational Infectious Diseases science. The editors welcome major articles and brief reports describing research results on microbiology, immunology, epidemiology, and related disciplines, on the pathogenesis, diagnosis, and treatment of Infectious Diseases; on the microbes that cause them; and on disorders of host immune responses. Ofid publishes clinical, translational and basic research in a fully open access, online journal. It focuses on the intersection of biomedical science and clinical practice, with an emphasis on knowledge that could improve patient care globally. Articles are written by experts in the field, including members and non-members, and reviewed by a panel of leading medical experts before they are published.